The stock of Philip Morris International Inc. (NYSE:PM) is a huge mover today! The stock increased 1.25% or $1 during the last trading session, reaching $81.03. About 2.49M shares traded. Philip Morris International Inc. (NYSE:PM) has declined 32.76% since June 19, 2017 and is downtrending. It has underperformed by 45.33% the S&P500. Some Historical PM News: ; 19/04/2018 – Philip Morris 1Q Adj EPS $1.00; 21/03/2018 – Philip Morris: Greece Factory Conversion Involved EUR300M Investment; 09/05/2018 – PHILIP MORRIS INTERNATIONAL – REVISES 2018 FULL-YEAR REPORTED DILUTED EPS GUIDANCE, FOR CURRENCY ONLY, TO RANGE OF $5.15 TO $5.30; 19/04/2018 – Buy Philip Morris Even as People Quit Smoking: Street Wrap; 27/03/2018 – New Zealand court gives Philip Morris nod to sell heated tobacco product; 09/05/2018 – Philip Morris Chairman Has Musk Moment at Shareholder Meeting; 19/04/2018 – Philip Morris 1Q Chesterfield Cigarette Shipment Volume Down Up 20%; 19/04/2018 – Philip Morris Sees 2018 Effective Tax Rate 26%; 20/04/2018 – Philip Morris Bond Trading 3x Average; 09/04/2018 – Fitch Sees Altria as Well-Positioned Through Its Licensing Agreement With Philip MorrisThe move comes after 7 months positive chart setup for the $125.96B company. It was reported on Jun, 19 by Barchart.com. We have $85.08 PT which if reached, will make NYSE:PM worth $6.30 billion more.
Among 29 analysts covering Edwards Lifesciences Corp (NYSE:EW), 22 have Buy rating, 1 Sell and 6 Hold. Therefore 76% are positive. Edwards Lifesciences Corp had 113 analyst reports since July 30, 2015 according to SRatingsIntel. Barclays Capital maintained Edwards Lifesciences Corporation (NYSE:EW) on Thursday, July 27 with “Equal-Weight” rating. The stock of Edwards Lifesciences Corporation (NYSE:EW) has “Hold” rating given on Thursday, October 26 by Deutsche Bank. The firm has “Buy” rating given on Thursday, December 7 by BMO Capital Markets. Canaccord Genuity maintained the shares of EW in report on Wednesday, February 3 with “Buy” rating. The firm earned “Buy” rating on Thursday, February 1 by Cowen & Co. SunTrust maintained it with “Neutral” rating and $100 target in Monday, March 7 report. The stock of Edwards Lifesciences Corporation (NYSE:EW) has “Outperform” rating given on Wednesday, October 26 by RBC Capital Markets. The company was maintained on Monday, July 10 by BMO Capital Markets. The stock of Edwards Lifesciences Corporation (NYSE:EW) has “Buy” rating given on Tuesday, September 5 by Jefferies. The rating was maintained by BTIG Research with “Buy” on Wednesday, July 27. See Edwards Lifesciences Corporation (NYSE:EW) latest ratings:
31/05/2018 Broker: Raymond James Rating: Outperform New Target: $152 Initiates Coverage On
25/04/2018 Broker: Canaccord Genuity Rating: Buy New Target: $174.0000 Maintain
25/04/2018 Broker: Northland Capital Rating: Hold Downgrade
24/04/2018 Broker: BTIG Research Rating: Hold
10/04/2018 Broker: SunTrust Rating: Buy New Target: $180.0000 Maintain
22/03/2018 Broker: Canaccord Genuity Rating: Buy New Target: $174.0 Maintain
20/03/2018 Broker: Cowen & Co Rating: Buy New Target: $165.0 Maintain
15/02/2018 Broker: Canaccord Genuity Rating: Buy New Target: $174.0 Maintain
02/02/2018 Broker: Guggenheim Rating: Buy New Target: $162.0 Maintain
01/02/2018 Broker: Stifel Nicolaus Rating: Buy New Target: $155.0 Maintain
Edwards Lifesciences Corporation provides products and technologies to treat structural heart disease and critically ill patients worldwide. The company has market cap of $32.32 billion. It offers transcatheter heart valve therapy products comprising transcatheter aortic heart valves and their delivery systems for the nonsurgical replacement of heart valves. It has a 59.02 P/E ratio. The firm also provides surgical heart valve therapy products, such as pericardial valves for aortic and mitral replacement, and minimally invasive aortic heart valve system; and tissue heart valves and repair products, which are used to replace or repair a patientÂ’s diseased or defective heart valve.
The stock increased 0.14% or $0.22 during the last trading session, reaching $153.33. About 559,175 shares traded. Edwards Lifesciences Corporation (NYSE:EW) has risen 19.08% since June 19, 2017 and is uptrending. It has outperformed by 6.51% the S&P500. Some Historical EW News: ; 25/04/2018 – EDWARDS LIFESCIENCES CORP EW.N : NORTHLAND CAPITAL CUTS TO MARKET PERFORM RATING; 01/05/2018 – Edwards Lifesciences Enters Into Accelerated Share Repurchase Agreement; 24/04/2018 – EDWARDS LIFESCIENCES – 2018 ADJ SHR OUTLOOK RAISED TO $4.50 TO $4.70 FROM $4.43 TO $4.63; 24/04/2018 – Edwards Lifesciences 1Q Adj EPS $1.22; 21/03/2018 – Edwards Completes Enrollment In PARTNER 3 Low-Risk CT Sub-Study, Updates Timeline For SAPIEN 3 Ultra System Launch In Europe; 20/04/2018 – DJ Edwards Lifesciences Corporation, Inst Holders, 1Q 2018 (EW); 21/03/2018 – EDWARDS LIFESCIENCES CORP – EDWARDS CONTINUES TO EXPECT U.S. INTRODUCTION OF SAPIEN 3 ULTRA SYSTEM IN LATE 2018; 24/04/2018 – Edwards Lifesciences reports 1.3 pct rise in quarterly sales; 22/03/2018 – Global Transcatheter Aortic Valve lmplantation (TAVI) Market Analysis & Outlook 2018-2022 with Profiles of Abbott Laboratories, Boston Scientific, Edwards Lifesciences & Medtronic – ResearchAndMarkets; 24/04/2018 – EDWARDS LIFESCIENCES – QTRLY TOTAL ADJ SALES $937.5 MLN, UP 9.3 PCT
More news for Edwards Lifesciences Corporation (NYSE:EW) were recently published by: Benzinga.com, which released: “Benzinga’s Daily Biotech Pulse: Biohaven Sells Right To Drug, Obseva To Sell Shares” on June 19, 2018. Ocbj.com‘s article titled: “Midday Stock Roundup” and published on June 13, 2018 is yet another important article.
More notable recent Philip Morris International Inc. (NYSE:PM) news were published by: Seekingalpha.com which released: “The Pain Of Philip Morris” on June 12, 2018, also Seekingalpha.com with their article: “Philip Morris: No Buyback Now” published on June 04, 2018, Seekingalpha.com published: “Philip Morris: A Killer Stock” on June 08, 2018. More interesting news about Philip Morris International Inc. (NYSE:PM) were released by: Seekingalpha.com and their article: “Philip Morris: Investors Are Ignoring This” published on May 28, 2018 as well as Investorplace.com‘s news article titled: “10 Consumer Stocks on the Clearance Rack” with publication date: June 18, 2018.
Investors sentiment decreased to 0.91 in Q1 2018. Its down 0.20, from 1.11 in 2017Q4. It dived, as 61 investors sold Philip Morris International Inc. shares while 545 reduced holdings. 126 funds opened positions while 427 raised stakes. 1.09 billion shares or 0.05% less from 1.09 billion shares in 2017Q4 were reported. 16,841 are held by Raab & Moskowitz Asset Management Lc. Moreover, Wolverine Asset Ltd Liability Company has 0% invested in Philip Morris International Inc. (NYSE:PM) for 600 shares. Hendley & Inc stated it has 15,016 shares or 0.79% of all its holdings. Jones Financial Cos Lllp holds 39,365 shares or 0.01% of its portfolio. Checchi Capital Advisers Limited Liability Corporation has 0.21% invested in Philip Morris International Inc. (NYSE:PM). Busey Trust Com reported 0.08% of its portfolio in Philip Morris International Inc. (NYSE:PM). Weik Cap reported 22,256 shares or 1.06% of all its holdings. 5,985 were reported by Merriman Wealth Mngmt Ltd. Grandfield And Dodd Limited Liability owns 12,559 shares. Connor Clark And Lunn Investment Ltd accumulated 535,307 shares. Chesley Taft And Lc reported 80,917 shares. Dowling And Yahnke Lc owns 6,949 shares for 0.06% of their portfolio. Insurance Tx holds 0.19% or 37,760 shares in its portfolio. Hm Payson And owns 78,713 shares for 0.32% of their portfolio. Torch Wealth Mngmt Limited Liability reported 0.3% of its portfolio in Philip Morris International Inc. (NYSE:PM).
Philip Morris International Inc., through its subsidiaries, makes and sells cigarettes, other tobacco products, and other nicotine-containing products. The company has market cap of $125.96 billion. The Company’s portfolio of brands comprises Marlboro, Merit, Parliament, Virginia S., L&M, Philip Morris, Bond Street, Chesterfield, Lark, Muratti, Next, and Red & White. It has a 21.01 P/E ratio. The firm also owns various cigarette brands, such as Dji Sam Soe, Sampoerna, and U Mild in Indonesia; Champion, Fortune, and Jackpot in the Philippines; Apollo-Soyuz and Optima in Russia; Morven Gold in Pakistan; Boston in Colombia; Belmont, Canadian Classics, and Number 7 in Canada; f6 in Germany; Delicados in Mexico; Assos in Greece; and Petra in the Czech Republic and Slovakia.
Since February 21, 2018, it had 4 insider buys, and 3 insider sales for $6.75 million activity. The insider Li Jennifer bought $3.25 million. FIRESTONE MARC S sold $1.43M worth of stock. 3,000 shares valued at $248,282 were bought by Whitson Jerry on Wednesday, April 25. $8.21M worth of Philip Morris International Inc. (NYSE:PM) was sold by CAMILLERI LOUIS C on Wednesday, May 9. Shares for $489,360 were bought by Zielinski Miroslaw on Friday, April 27. Geissler Werner bought 48,750 shares worth $3.97M. Another trade for 49,000 shares valued at $5.08 million was sold by CALANTZOPOULOS ANDRE.
Among 21 analysts covering Philip Morris International (NYSE:PM), 16 have Buy rating, 1 Sell and 4 Hold. Therefore 76% are positive. Philip Morris International had 63 analyst reports since August 24, 2015 according to SRatingsIntel. Piper Jaffray maintained the shares of PM in report on Thursday, January 11 with “Buy” rating. The firm earned “Underperform” rating on Friday, April 20 by Bank of America. Jefferies maintained the shares of PM in report on Friday, October 20 with “Hold” rating. Piper Jaffray maintained Philip Morris International Inc. (NYSE:PM) rating on Thursday, October 19. Piper Jaffray has “Buy” rating and $130.0 target. Citigroup initiated the shares of PM in report on Tuesday, September 13 with “Neutral” rating. Morgan Stanley maintained the stock with “Overweight” rating in Tuesday, January 30 report. The stock has “Buy” rating by Stifel Nicolaus on Wednesday, January 10. The stock of Philip Morris International Inc. (NYSE:PM) has “Neutral” rating given on Friday, October 20 by Bank of America. The company was upgraded on Monday, November 30 by Nomura. The firm earned “Buy” rating on Monday, October 3 by Goldman Sachs.
Analysts await Philip Morris International Inc. (NYSE:PM) to report earnings on July, 19. They expect $1.25 EPS, up 9.65% or $0.11 from last year’s $1.14 per share. PM’s profit will be $1.94B for 16.21 P/E if the $1.25 EPS becomes a reality. After $1.00 actual EPS reported by Philip Morris International Inc. for the previous quarter, Wall Street now forecasts 25.00% EPS growth.